News

From Mahito to Yuno Gasai, these modern anime villains had the potential to be great, but they just didn’t stick the landing.
You don’t need purely Italian ingredients to make authentic Italian food. Or at least that’s what a small, cozy eatery in ...
A new study to be presented at the SLEEP 2025 annual meeting found that poor sleep quality is related to relationship insecurity, which moderates the effect of sleep quality on daily feelings of ...
One of the most striking things about Bungie’s Marathon is its presentation ... but clearly my work was good enough to pillage for ideas and plaster all over their game without pay or ...
If heated fan backlash is anything to go by, the new poster design isn't nearly as popular as they'd anticipated. Credit: Universal Pictures On first impressions, the new Wicked: For Good poster ...
The poster is scheduled for presentation on May 31, 2025, from 01:30pm to 04:30pm CDT in the Lung Cancer track. "We continue to believe that our telomere targeting agent ateganosine (THIO ...
For Good, with Universal Pictures announcing the release date of its first trailer while unveiling the film’s poster Wednesday (May 14). As revealed first on the official Wicked Instagram ...
Fans are finally getting their first looks at Wicked: For Good, with Universal Pictures announcing the release date of its first trailer while unveiling the film’s poster Wednesday (May 14).
Late-Breaking scientific poster at the American Thoracic Society Advances in Pulmonary Vascular Disease sessions will present AV-001 activity in SARS-CoV-2 Infection/COVID-19 Vasomune Therapeutics ...
JTBC’s upcoming drama “Good Boy” has confirmed its premiere date with a poster featuring Park Bo Gum! “Good Boy” is a comic action drama about young athletes who become police officers ...
Abstract and poster presentation details are below: Title: "Phase 1 dose escalation results of the WEE1 inhibitor, azenosertib, in combination with encorafenib and cetuximab in patients with ...
TAIPEI, Taiwan, April 23, 2025 (GLOBE NEWSWIRE) — OBI Pharma, Inc. (TPEx: 4174. TWO) today announced nonclinical data for OBI-902, a potential best-in-class anti-TROP2 ADC developed using the ...